大鼠脑红蛋白(NGB)可溶性原核表达和单克隆抗体制备及鉴定

脑红蛋白 (NGB)是新发现的脑特异的携氧蛋白 .为了对其功能进行深入的研究 ,应用已构建大鼠NGB基因编码区原核表达载体pGEX 4T 2 NGB转化的大肠杆菌BL2 1 ,获得可溶性表达产物 .用谷胱甘肽S 转移酶 (GST)亲和层析柱纯化后作为抗原 ,免疫Balb c小鼠 .通过传统的细胞融合方法制备了抗大鼠NGB的单克隆抗体 ,并对全部 4株单抗进行了亚类和亚型、效价和特异性鉴定 .为NGB结构与功能的深入研究提供了重要工具     

一个新的HMT家族成员SET07的理化性质及其功能

近年来发现组蛋白的甲基化可以改变染色体的状态,进而调节基因的转录、细胞周期、个体发育以及肿瘤发生.对本实验室新近克隆的组蛋白甲基转移酶基因家族新成员SET07理化性质,是否具有甲基转移酶的功能进行初步研究.构建pGEX4T2P2RP2质粒,并对其进行表达和纯化;利用硝纤膜及原核表达产物免疫昆明鼠制备抗SET07多克隆抗体;采用Western印迹对其蛋白水平的表达进行观察;利用HMT(组蛋白甲基转移酶)实验观察表达纯化的SET07蛋白是否具有甲基转移酶的功能.经大肠杆菌表达及纯化获得了较纯的GSTSET07片段,制备获得的多克隆抗体效价高于1∶1000;Western印迹发现SET07蛋白存在于胞核及胞浆.其中在胞核中以49kD存在,在胞浆中SET07以4种形式存在;HMT实验证明,表达纯化的SET07蛋白具有组蛋白甲基转移酶的功能.上述结果提示,SET07可能在合成后经过加工修饰以复合体的形式在胞核内发挥甲基转移酶作用,为进一步研究SET07基因的作用机制、SET07与个体发育、肿瘤发生之间的关系奠定基础.     

人GST-AWP1融合蛋白的原核表达及其抗体制备

为进一步研究人的一新蛋白———蛋白激酶C相关激酶 1相关蛋白 (AWP1)的结构、功能及与其相互作用的蛋白而进行GST AWP融合蛋白表达载体的构建、原核表达、纯化及其抗体的制备 .采用逆转录PCR(RT PCR)法从人ECV30 4内皮细胞中扩增AWP1cDNA编码区 ,并将其重组于谷胱甘肽硫转移酶 (GST)融合蛋白表达质粒pGEX KG中 .经酶切、序列鉴定分析后 ,用该重组质粒转化大肠杆菌BL2 1,并经异丙基 β D 硫代半乳糖苷 (IPTG)诱导产生GST AWP1融合蛋白 ,继而纯化获得了分子量约 5 6kD的融合蛋白 .将此融合蛋白免疫新西兰兔 ,经ELISA和Western印迹检测获得了效价高、免疫活性强的兔抗人多克隆抗体 .结果表明成功构建了GST AWP1融合蛋白表达载体 ,在大肠杆菌高效表达了GST AWP1融合蛋白 ,并获得高效多抗 ,为下阶段深入AWP1功能研究提供了重要的基础     

人凋亡相关基因TFAR19缺失突变体的原核表达、产物纯化及鉴定

构建TF 1细胞凋亡相关基因 19(TF 1cellapoptosisrelatedgene 19,TFAR19)缺失突变体的原核表达载体 ,获取缺失突变体蛋白 ,用于TFAR19促凋亡分子机理的研究 .从真核表达载体pcDI TFAR19扩增出野生型TFAR19和 4个缺失突变体 ,重组到原核表达载体pGEX 4T 2 .经亲和层析方法对缺失体蛋白进行纯化后 ,再利用凝胶过滤的方法进一步纯化 .利用抗GST和抗TFAR19的单克隆抗体对蛋白进行免疫学鉴定 .用白血病细胞株HL 6 0检测蛋白活性 .成功地克隆并重组了野生型TFAR19及缺失突变体 pGEX 4T 2表达载体 ,对融合蛋白的表达条件进行了优化 .SDS PAGE结果显示 ,各个缺失突变体融合蛋白均有较高水平的表达 .免疫学检测证实获得了正确的表达产物 .活性检测证实 ,野生型TFAR19和缺失突变体 4可以明显促进去血清诱导的HL 6 0细胞凋亡 ,第 6外显子可能是一个与TFAR19促凋亡活性密切相关的功能结构域     

弗氏2a志贺氏菌2457T株YciD蛋白的融合表达和纯化

目的：原核表达重组弗氏2a志贺氏菌2457T株YciD蛋白,为其功能研究奠定基础。方法：用PCR方法从弗氏2a志贺氏菌2457T株染色体中扩增YciD蛋白编码序列,经过纯化、酶切后克隆到原核表达载体pET32a中,构建重组载体pET32a-yciD,转化大肠杆菌BL21（DE3）菌株获得工程菌株,对其表达和纯化条件进行优化;利用Western Blot检测融合蛋白的表达。结果：构建了YciD蛋白的融合表达载体,并在大肠杆菌中获得高效表达;经Ni-NTA亲和层析柱纯化获得了高纯度的YciD蛋白;Western Blot表明,此蛋白可与His标签抗体反应,表明获得了目的蛋白。结论：在原核表达系统中表达、纯化弗氏2a志贺氏菌2457T株YciD蛋白,为进一步对其进行功能研究奠定了基础。     

GST-H2AX表达载体的构建及融合蛋白的纯化

H2AX属组蛋白H2A家族成员,其磷酸化是细胞对DNA损伤做出反应的早期事件之一,在启动DNA修复过程中发挥重要功能.利用原核表达载体pGEX-4T-1构建了GST-H2AX融合蛋白表达载体,导入大肠杆菌DE3后经IPTG诱导和GST(Glutathione S-transferase)磁珠纯化获得GST-H2AX融合蛋白.进一步利用GST和H2AX抗体对融合蛋白进行了验证.既建立了高效、稳定的GST蛋白纯化方法,也为进一步研究H2AX结构及生物学功能奠定了基础.     

人细胞核dUTPase的克隆表达及其酶学活性

以阿尔茨海默病 (Alzheimer’sdisease ,AD)患者脑cDNA文库质粒为模板 ,用PCR方法扩增得到人细胞核dUTP焦磷酸酶 (dUTPase)的cDNA ,将其克隆到谷胱甘肽 S 转移酶 (GST)融合表达载体pGEX 4T 1中 ,并在大肠杆菌BL2 1中获得高效表达 .表达的融合蛋白GST dUTPase经过谷胱甘肽 Sepharose 4B亲和层析 ,凝血酶酶切和SephacrylS 10 0纯化 ,得到高纯度dUTPase蛋白 .通过SDS PAGE ,氨基酸组成分析 ,N端氨基酸序列测定以及HPLC测Mr 结果与期望值一致 .通过检测该酶水解dUTP释放的焦磷酸 (PPi)来测定表达产物dUTPase蛋白及GST dUTPase融合蛋白的酶活性 ,发现两蛋白都具有正常的酶水解dUTP活性 ,但融合蛋白的活性比dUTPase蛋白低 7～ 8倍 .同时研究了Mg2 +和EDTA对酶活性的影响     

人造血相关PBX相互作用蛋白的原核表达及纯化鉴定

目的:构建带His标签的人造血相关PBX相互作用蛋白(HPIP)的原核表达载体,获得His-HPIP融合蛋白,并对其生物学功能进行初步检测。方法:以本实验室保存的pcDNA3.0-HPIP质粒为模板,采用PCR技术扩增HPIP编码序列,将其插入载体p ET-28a(+)中,经Bam HⅠ和HindⅢ双酶切鉴定后转化大肠杆菌Rossate株进行小量诱导,挑选能诱导出His-HPIP的菌液进行融合蛋白的纯化,采用SDS-PAGE和Western印迹检测融合蛋白的纯化效果,采用GST pull-down技术对蛋白的生物学功能进行初步鉴定。结果:双酶切和测序结果表明His-HPIP原核表达质粒构建成功;His pull-down实验证实His-HPIP蛋白和雌激素受体α存在相互作用,说明生物学活性良好。结论:原核表达并纯化出His-HPIP融合蛋白,为进一步研究HPIP在肿瘤发生发展中的功能奠定了基础。     

大鼠脑红蛋白(NGB)的原核表达、抗体制备及其细胞分布

脑红蛋白 (NGB)是新发现的与脑内氧供应密切相关的分子 .为了检测细胞内脑红蛋白的表达、亚细胞分布从而对该分子进行深入的功能研究 ,成功地将大鼠脑红蛋白基因编码区构建于原核表达载体pGEX 4T 2 ,转化大肠杆菌BL2 1(DE3) ,获得融合表达产物 .对含有融合蛋白的包含体进行溶解和复性 ,用谷胱甘肽S 转移酶 (GST)亲和层析柱纯化 ,通过免疫家兔获得了兔源性抗NGB多克隆抗体 .采用Western印迹分析技术 ,用该抗体检测NGB基因的真核表达产物 ,证明该抗体有较好的针对NGB蛋白的专一性 ,可用于对NGB的结构和功能研究 .同时 ,用该抗体进行免疫组化分析发现 ,正常成年大鼠神经系统中有较多的NGB免疫反应阳性细胞分布 ,提示NGB是与神经系统功能密切相关的重要分子     

炭疽芽孢杆菌EA1蛋白的融合表达和纯化

目的：原核表达重组炭疽芽孢杆菌EA1蛋白。方法：用PCR方法从炭疽芽孢杆菌A16R疫苗株染色体中扩增编码EA1蛋白的eag基因序列,经过纯化、酶切后克隆到含有GST标签的原核表达载体pGEX-6P-2中,构建重组载体pGEX-EA1;将空载体（作为对照）、重组载体转化大肠杆菌BL21（DE3）菌株获得表达工程菌株,对其表达和纯化条件进行优化;利用Western印迹检测融合蛋白的表达。结果：构建了EA1蛋白的融合表达载体,并在大肠杆菌中获得高效表达;经Glutathione Sepharose 4B纯化获得了EA1蛋白;Western印迹表明,此蛋白可与GST标签抗体反应。结论：在原核表达系统中表达并纯化得到EA1融合蛋白,为进一步对其进行功能研究奠定了基础。     

TGF-β1 increases invasiveness of SW1990 cells through Rac1/ROS/NF-κB/IL-6/MMP-2

Post-translational acetylation is an important molecular regulatory mechanism affecting the biological activity of proteins. Polypeptide GalNAc transferases (ppGalNAc-Ts) are a family of enzymes that catalyze initiation of mucin-type O-glycosylation. All ppGalNAc-Ts in mammals are type II transmembrane proteins having a Golgi lumenal region that contains a catalytic domain with glycosyltransferase activity, and a C-terminal R-type (“ricin-like”) lectin domain. We investigated the effect of acetylation on catalytic activity of glycosyltransferase, and on fine carbohydrate-binding specificity of the R-type lectin domain of ppGalNAc-T2. Acetylation effect on ppGalNAc-T2 biological activity in vitro was studied using a purified human recombinant ppGalNAc-T2. Mass spectrometric analysis of acetylated ppGalNAc-T2 revealed seven acetylated amino acids (K103, S109, K111, K363, S373, K521, and S529); the first five are located in the catalytic domain. Specific glycosyltransferase activity of ppGalNAc-T2 was reduced 95% by acetylation. The last two amino acids, K521 and S529, are located in the lectin domain, and their acetylation results in alteration of the carbohydrate-binding ability of ppGalNAc-T2. Direct binding assays showed that acetylation of ppGalNAc-T2 enhances the recognition to αGalNAc residue of MUC1αGalNAc, while competitive assays showed that acetylation modifies the fine GalNAc-binding form of the lectin domain. Taken together, these findings clearly indicate that biological activity (catalytic capacity and glycan-binding ability) of ppGalNAc-T2 is regulated by acetylation.     

O-糖基化起始糖基转移酶的活性与结构研究

多肽：N-乙酰氨基半乳糖转移酶（ppGalNAc-T） 是催化N-乙酰氨基半乳糖（GalNAc）结合到蛋白质Ser或Thr上的糖基转移酶,是黏蛋白型O-糖基化修饰的起始糖基转移酶。ppGalNAc-T是一个酶家族,表达产物均为Ⅱ型膜蛋白。虽然氨基酸序列高度同源,但各成员具有独特的底物特异性和动力学特征。因此,ppGalNAc-T的底物作用机制是O-糖基化研究领域中的关键课题。近年来,通过利用定点突变及晶体结构解析技术,ppGalNAc-T中与底物相互作用的重要氨基酸残基以及由这些残基所形成的对底物结合起关键作用的空间构象逐渐被揭示,为了解ppGalNAc-T酶家族的底物作用机制及其蛋白结构与催化活性间的关系提供了理论依据。     

Expression of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 in gastric mucosa, intestinal metaplasia, and gastric carcinoma

Aberrant mucin O-glycosylation is often observed in cancer and is characterized by the expression of immature simple mucin-type carbohydrate antigens. UDP-N-acetyl-d-galactosamine:polypeptide N-acetylgalactosaminyltransferase-6 (ppGalNAc-T6) is one of the enzymes responsible for the initial step in O-glycosylation. This study evaluated the expression of ppGalNAc-T6 in human gastric mucosa, intestinal metaplasia, and gastric carcinomas. Our results showed that ppGalNAc-T6 is expressed in normal gastric mucosa and in intestinal metaplasia. A heterogeneous expression and staining pattern for this enzyme was observed in gastric carcinomas. ppGalNAc-T6 was expressed in 79% of the cases, and its expression level was associated with the presence of venous invasion. Our results provide evidence that ppGalNAc-T6 is an IHC marker associated with venous invasion in gastric carcinoma and may contribute to the understanding of the molecular mechanisms that underlie aberrant glycosylation in gastric carcinogenesis and in gastric carcinoma.     

UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 as a new immunohistochemical breast cancer marker.

Mucin O-glycosylation is characterized in cancer by aberrant expression of immature carbohydrate structures (Tn, T, and sialyl-Tn antigens). The UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferases (ppGalNAc-T) family enzymes regulate the initial steps of mucin O-glycosylation and could be responsible for the altered glycosylation observed in cancer. Considering that we recently found the ppGalNAc-T6 mRNA expressed in breast carcinomas, we produced a highly specific monoclonal antibody (MAb T6.3) to assess the expression profile of ppGalNAc-T6 protein product in breast tissues. The expression of ppGalNAc-T6 by breast carcinoma cells was confirmed on MCF-7 and T47D cell lines. In formalin-fixed tissues, ppGalNAc-T6 expression was observed in 60/74 (81%) breast cancers, 21/23 (91.3%) adjacent ductal carcinoma in situ (DCIS), 4/20 benign breast lesions (2/2 sclerosing adenosis and 2/13 fibroadenoma), and in 0/5 normal breast samples. We observed a statistically significant association of ppGalNAc-T6 expression with T1 tumor stage. This fact, as well as the observation that ppGalNAc-T6 was strongly expressed in sclerosing adenosis and in most DCIS, suggests that ppGalNAc-T6 expression could be an early event during human breast carcinogenesis. Considering that an abnormal O-glycosylation greatly contributes to the phenotype and biology of breast cancer cells, ppGalNAc-T6 expression could provide new insights about breast cancer glycobiology.     

油菜AP2/ERF-B4类转录因子克隆及表达载体的构建

利用油菜UniGene数据库,以拟南芥转录因子保守序列为探针,通过电子克隆方法分离得到一个UniGene库Bna.17538,进一步序列拼接得到一个油菜AP2/ERF-B4亚族的转录因子BnaERFB4-1,长度为672 bp,并进行了相关的生物信息学分析.结果显示BnaERFB4-1是亲水性蛋白,蛋白质三级结构与拟南芥RAP2.6L非常相似,蛋白质无序化程度大于拟南芥RAP2.6L.设计引物通过PCR和RT-PCR方法分别从甘蓝型油菜沪油15幼苗的DNA和cDNA中分离了BnaERFB4-1基因,命名为BnaERFB4-1-Hy15.序列测定和分析显示,来源于沪油15的BnaERFB4-1-Hy15基因与电子克隆的基因序列差异很小,有3个氨基酸位点不同,存在一个内含子.将BnaERFB4-1-Hy15基因通过BamHⅠ和SacⅠ酶切后分别插入酵母表达载体YK3302和植物双元表达载体pYF1404的相应位置,构建了BnaERFB4-1-Hy15基因的酵母体内结合和植物转化载体,为深入研究该基因在油菜抗逆调控中的作用奠定了基础.     

三角酵母D—氨基酸氧化酶基因的克隆,测序及表达

利用跨越内含子的ＰＣＲ技术,从三角酵母（Ｔｒｉｇｏｎｏｐｓｉｓｖａｒｉａｂｉｌｉｓ）变种ＦＡ１１０中扩增得到Ｄ氨基酸氧化酶基因（ｄａａｏ）,并通过ＴＡ克隆的方法将其克隆至ｐＧＥＭＴ载体。序列测定结果表明,所得ｄａａｏ基因的５′端内含子已被删除,基因总长度为１０７１ｂｐ,它与Ｔｒｉｇｏｎｏｐｓｉｓｖａｒｉａｂｉｌｉｓ的Ｄ氨基酸氧化酶同源性达９８３％,与Ｆｕｓａｒｉｕｍｓｏｌａｎｉ和Ｒｈｏｄｏｔｏｒｕｌａｇｒａｃｉｌｉｓ的同源性分别是３８９％和３０８％。为提高表达水平,又将此基因转移至高表达载体ｐＥＴ２８ｂ上,在大肠杆菌ＢＬ２１（ＤＥ３）中进行诱导表达。经ＩＰＴＧ诱导,目的蛋白的产生量可占菌体总蛋白量的４６％,分子量约为３８ｋＤ。Ｄ氨基酸氧化酶的活力可达８０２ｕ／Ｌ。     

The C-terminal region controls correct folding of genus Trametes pyranose 2-oxidases

The pyranose 2-oxidases from Trametes ochracea and Trametes pubescens share markedly similar amino acid sequences with identity of 93.4%. When expressed from the recombinant plasmids based on the same vector in the Escherichia coli host strain BL21(DE3) at higher growth temperatures, they differ strikingly in the formation of the inclusion bodies. Upon overexpression in the cultures performed at 28 degrees C, the specific activity of pyranose 2-oxidase from T. pubescens was eight times higher than that from T. ochracea: 93% of pyranose 2-oxidase from T. ochracea and only 15% of that from T. pubescens was present in the form of inclusion bodies. To ascertain the cause of this difference, both cloned genes were shuffled. Site-directed recombination of p2o cDNAs revealed that DNA constructs ending with 3' end of p2o cDNA from T. pubescens code for proteins that are folded into an active form to the greater extent, regardless of the gene expression level. "In silicio" analysis of physico-chemical properties of the protein sequences of pyranose 2-oxidases revealed that the sequence of amino acid residues 368-430, constituting the small, head domain of pyranose 2-oxidase from T. pubescens, affects positively the enzyme folding at higher cultivation temperatures. The domain differs in six amino acid residues from that of T. ochracea.     

野桑蚕GST-Omega1基因在草地贪夜蛾Sf9细胞中的表达

谷胱甘肽 S-转移酶（glutathione S-transferases,GSTs）是昆虫的重要解毒酶之一。为了研究野桑蚕Bombyx mandarina中谷胱甘肽S-转移酶在真核表达系统中的表达情况。本研究通过RT-PCR从野桑蚕中肠中获得GST-Omega1基因的cDNA序列,该基因的开放读码框为771 bp,编码256 个氨基酸。对推导的氨基酸序列用NCBI的蛋白质Conserved Domains工具进行在线分析,结果显示GST-Omega1的氨基酸序列中具有Cys38和8个GSH结合位点的Omega类基因保守序列。对所获得的基因克隆进表达载体pFastBacHT b中获得pFast-GST-Omega1,将其转化DH10Bac感受态细胞,获得Bac-GST-Omega1重组病毒DNA,用脂质体法转染草地贪夜蛾Sf9细胞,获得重组病毒。对表达产物经SDS-PAGE和Western blotting分析,能检测到一条分子量约为33 kD的特异性条带,与推导的融合蛋白大小相符,该目的蛋白的表达量占总蛋白的14.4%。目的蛋白经His·Bind树脂纯化,用Lineweaver Burk作图法测定其K_m和V_max,结果显示其K_m为2.81 µmol/L,V_max为2.70 µmol/(mg·min）。     

O-glycosylation of mucin-like domain retains the neutral ceramidase on the plasma membranes as a type II integral membrane protein

Ceramidase is a key enzyme involved in regulating cellular levels of ceramide, sphingosine, and possibly sphigosine 1-phosphate and thus could modulate sphingolipid signaling. Here we report that O-glycosylation of the mucin-like domain of neutral ceramidases was required for localization to the surface of plasma membranes. The deduced amino acid sequences of the mammalian enzymes contain a serine-threonine-rich domain (mucin box), which follows the signal/anchor sequence, whereas those of bacterial and invertebrate enzymes completely lack a mucin box, suggesting that the specific domain has been acquired during evolution. In HEK293 cells overexpressing ceramidase, the enzyme was not only secreted into the medium after cleavage of the NH(2)-terminal signal/anchor sequence but also localized at the plasma membrane as a type II integral membrane protein. Lectin blot analysis using peanut agglutinin revealed that the mucin box of the enzyme is highly glycosylated with O-glycans. Interestingly, a mutant lacking the mucin box or possible O-glycosylation sites in the mucin box was secreted into the medium but not localized at the surface of the cells. Furthermore, a mucin box-fused chimera green fluorescent protein (GFP), but not GFP itself, with the signal/anchor sequence was distributed on the surface of the cells. These results suggest that O-glycosylation of the mucin box retains proteins on the plasma membranes. We also found that the 112-kDa membrane-bound enzyme from mouse kidney is O-glycosylated, whereas the 94-kDa soluble enzyme from liver is not. These results clearly indicate that post-translational modification of the enzyme with O-glycans is tissue-specific and helps the enzyme to localize at the surface of plasma membranes as a type II membrane protein.